Velleca Mark A. - Insider Non-Derivative Transactions at G1 Therapeutics, Inc. (GTHX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 8, 2023, Velleca Mark A.'s relationship to G1 Therapeutics, Inc. (GTHX) is Director, and currently has 173,286 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other GTHX insiders.
Data Source: SEC.
Velleca Mark A. - Insider Non-Derivative Transactions at GTHX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 9, 2023 | Sell -- (Common Stock) | 2714 | 2.02 | 116000 |
| Aug 9, 2023 | Sell -- (Common Stock) | 57286 | 2 | 116000 |
| Aug 9, 2023 | M -- (Common Stock) | 2714 | 0.3 | 118714 |
| Aug 9, 2023 | M -- (Common Stock) | 57286 | 0.39 | 173286 |